Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Middletown › NPI 1952376410
Physician

Crystal Run Healthcare Physicians LLP

Crystal Run Healthcare Physicians LLP was paid $34.14M by Medicaid between Jan 2018 and Dec 2024, across 316 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.

33Billing provider infoCRYSTAL RUN HEALTHCARE PHYSICIANS LLP
MIDDLETOWN, NY 10941
33aNPI1952376410assigned 02/20/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$34.14M
24GClaims537,971
24DCodes billed316
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Cardiovascular Disease Physician providers in New York

Rank by total paid#1 of 1,564
Median peer was paid$13K
This provider vs. median2,623×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018165,365$10.91M
201993,800$5.69M
2020107,294$6.39M
202154,079$3.67M
202243,058$2.81M
202311,756$673K
2024incomplete62,619$4.00M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 29% 82,602 77,647 $10.05M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 23% 92,951 86,410 $7.85M
88305 Level IV - Surgical pathology, gross and microscopic examination 4.0% 10,710 6,598 $1.38M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.3% 3,790 3,672 $773K
90460 Immunization administration through 18 years of age via any route, first or only component 2.3% 29,915 29,596 $771K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 2.1% 6,115 5,253 $710K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.1% 5,439 5,373 $709K
76819 Fetal biophysical profile; without non-stress testing 1.7% 6,347 3,844 $595K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.7% 4,550 4,492 $591K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.7% 6,125 6,116 $576K
77067 Screening mammography, bilateral, including computer-aided detection 1.3% 2,868 2,864 $445K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 6,330 3,297 $386K
304 more codes
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.1% 4,135 $377K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.1% 4,418 $376K
S9083 Global fee urgent care centers 1.1% 2,429 $361K
76830 Ultrasound, transvaginal 1.0% 2,717 $351K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 11,591 $336K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,394 $279K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,508 $260K
76820 <1% 5,176 $240K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,667 $232K
76801 <1% 1,639 $222K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,112 $169K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,101 $168K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 1,798 $161K
76813 <1% 1,191 $149K
99215 Doctor's office visit, returning patient (complex) <1% 832 $148K
59400 Routine obstetric care including antepartum care, vaginal delivery, and postpartum care <1% 45 $143K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 624 $141K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,095 $136K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,289 $134K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 445 $134K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 912 $132K
76536 <1% 1,054 $132K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,205 $126K
80053 Comprehensive metabolic panel <1% 10,294 $119K
90834 Psychotherapy session, about 45 minutes <1% 1,609 $116K
84443 Thyroid stimulating hormone (TSH) <1% 6,426 $114K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,228 $110K
87481 <1% 1,432 $105K
80061 Lipid panel <1% 7,118 $102K
99232 Hospital visit by a doctor, follow-up day <1% 1,134 $98K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 11,504 $97K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 428 $97K
36415 Collection of venous blood by venipuncture <1% 36,419 $96K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,598 $94K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,096 $85K
99223 Prolong inpt eval add15 m <1% 354 $84K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,975 $78K
71046 Radiologic examination, chest; 2 views <1% 2,211 $78K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 881 $78K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 55 $77K
92551 <1% 7,151 $69K
80050 General health panel <1% 1,493 $68K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,325 $66K
90461 <1% 2,404 $63K
83036 Hemoglobin; glycosylated (A1C) <1% 6,208 $60K
99205 Prolong outpt/office vis <1% 210 $58K
88141 <1% 1,941 $56K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 195 $54K
99222 Initial hospital care, per day, moderate complexity <1% 304 $53K
20610 <1% 748 $53K
97799 <1% 824 $53K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 391 $52K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,494 $51K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 922 $50K
87631 <1% 314 $50K
92134 <1% 1,086 $48K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 5,353 $46K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 385 $46K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 160 $43K
A4550 Surgical trays <1% 98 $43K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 954 $42K
99385 <1% 249 $42K
59510 <1% 13 $42K
93000 <1% 1,983 $40K
88342 <1% 305 $40K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,146 $38K
76641 <1% 224 $36K
90686 <1% 10,197 $35K
96127 <1% 6,190 $34K
73562 <1% 730 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 319 $32K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 1,639 $31K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 100 $31K
73630 <1% 775 $30K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,630 $30K
95117 <1% 2,012 $28K
99386 <1% 139 $28K
87070 <1% 2,436 $27K
73221 <1% 84 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,030 $25K
99239 Hospital discharge day management, more than 30 minutes <1% 192 $24K
99459 <1% 776 $23K
82607 <1% 1,200 $22K
99238 Hospital discharge day management, 30 minutes or less <1% 247 $21K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 617 $21K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 42 $21K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 195 $21K
20553 <1% 307 $20K
59025 Fetal non-stress test <1% 285 $19K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,555 $17K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 24 $17K
0011A <1% 505 $17K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 94 $17K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 39 $16K
0012A <1% 432 $16K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 107 $15K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 307 $15K
73610 <1% 392 $15K
92133 <1% 320 $14K
82728 <1% 834 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,328 $13K
87634 <1% 185 $13K
99221 <1% 138 $13K
72141 <1% 54 $13K
59514 <1% 15 $12K
97161 <1% 153 $12K
81025 <1% 1,349 $11K
92020 <1% 339 $11K
80048 Basic metabolic panel (calcium, ionized) <1% 1,107 $11K
82746 <1% 602 $11K
95953 <1% 18 $11K
95806 <1% 53 $10K
73030 <1% 287 $10K
84439 <1% 868 $10K
90715 <1% 381 $10K
93015 <1% 102 $10K
99070 <1% 14 $10K
99173 <1% 2,254 $10K
97802 <1% 84 $9K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 861 $8K
70551 Magnetic resonance imaging, brain; without contrast material <1% 27 $8K
87660 <1% 313 $8K
87510 <1% 313 $8K
87480 <1% 313 $8K
99460 <1% 65 $8K
73110 <1% 185 $8K
58300 <1% 77 $7K
96160 <1% 2,987 $7K
95886 <1% 68 $7K
81513 <1% 55 $7K
73130 <1% 184 $7K
86140 <1% 1,073 $7K
83655 <1% 476 $7K
83550 <1% 653 $7K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 105 $7K
92557 <1% 153 $7K
93224 <1% 56 $7K
87077 <1% 518 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 407 $6K
67028 Intravitreal injection of a pharmacologic agent <1% 50 $6K
64615 <1% 29 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 248 $6K
86618 <1% 280 $6K
72110 <1% 113 $6K
86762 <1% 327 $6K
90661 <1% 1,727 $6K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 13 $5K
99381 <1% 43 $5K
90651 <1% 422 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 27 $5K
83540 <1% 653 $5K
86803 <1% 310 $5K
92235 <1% 36 $5K
85027 <1% 602 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 28 $4K
86787 <1% 284 $4K
58301 <1% 35 $4K
87420 <1% 322 $4K
82043 <1% 609 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 125 $4K
90670 <1% 1,551 $4K
84702 <1% 222 $4K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 20 $4K
81003 <1% 1,575 $4K
92567 <1% 218 $4K
82570 <1% 613 $4K
93351 <1% 12 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 48 $4K
85652 <1% 1,114 $4K
73502 <1% 81 $4K
72100 <1% 91 $4K
87150 <1% 83 $4K
85018 <1% 1,276 $4K
99462 <1% 69 $3K
70450 Computed tomography, head or brain; without contrast material <1% 24 $3K
87186 <1% 307 $3K
88142 <1% 136 $3K
0064A <1% 118 $3K
83001 <1% 141 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 64 $3K
J2785 Injection, regadenoson, 0.1 mg <1% 13 $3K
94729 <1% 42 $3K
17110 <1% 27 $3K
93970 <1% 12 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 94 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 320 $3K
84460 <1% 427 $3K
99188 <1% 183 $3K
A9585 Injection, gadobutrol, 0.1 ml <1% 85 $3K
31231 <1% 12 $3K
84153 <1% 108 $2K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 133 $2K
84450 <1% 408 $2K
84146 <1% 97 $2K
82670 <1% 63 $2K
0031A <1% 57 $2K
94726 <1% 27 $2K
72040 <1% 57 $2K
85610 <1% 399 $2K
86580 <1% 206 $2K
73140 <1% 55 $2K
99406 <1% 112 $2K
86376 <1% 101 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 19 $2K
90707 <1% 759 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 18 $2K
83002 <1% 78 $2K
77065 Tomosynthesis, mammo <1% 12 $2K
20611 <1% 13 $2K
84481 <1% 78 $2K
86703 <1% 96 $2K
94010 <1% 34 $2K
93298 <1% 15 $2K
83735 <1% 190 $1K
82550 <1% 178 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 333 $1K
99242 <1% 12 $1K
82247 <1% 249 $1K
99441 <1% 18 $1K
87071 <1% 120 $1K
82950 <1% 223 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 232 $1K
83690 <1% 150 $1K
99217 <1% 13 $1K
84075 <1% 210 $1K
92083 <1% 15 $1K
81001 <1% 299 $1K
82150 <1% 141 $1K
85730 <1% 146 $1K
94060 <1% 13 $1K
77080 <1% 26 $1K
84466 <1% 78 $1K
90734 <1% 337 $1K
98925 <1% 28 $1K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 71 $989.60
69210 <1% 12 $967.35
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 43 $966.97
86431 <1% 138 $966.00
86765 <1% 61 $964.95
86735 <1% 59 $926.25
0071A <1% 41 $800.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16 $766.91
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 27 $650.16
99442 <1% 12 $643.76
86800 <1% 29 $624.90
73080 <1% 17 $580.21
84550 <1% 103 $574.74
81002 <1% 151 $515.04
90716 <1% 321 $497.32
82951 <1% 28 $444.92
90472 Immunization administration, each additional vaccine (list separately) <1% 40 $430.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 26 $405.60
0002A <1% 12 $390.85
86780 <1% 29 $383.96
86160 <1% 13 $370.25
0072A <1% 18 $360.00
90697 <1% 71 $306.20
83615 <1% 41 $305.45
90677 <1% 170 $266.70
0001A <1% 23 $264.31
87340 <1% 25 $258.25
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 134 $256.68
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 182 $252.45
99000 <1% 1,504 $210.00
80047 <1% 13 $178.49
96040 <1% 12 $158.73
36416 <1% 1,467 $141.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 91 $137.13
87205 <1% 26 $135.15
3078F <1% 3,544 $120.00
3074F <1% 5,021 $100.00
82962 <1% 31 $94.87
82565 <1% 14 $88.62
85045 <1% 13 $64.09
84520 <1% 13 $63.44
85007 <1% 26 $59.36
82040 <1% 14 $29.70
90633 <1% 503 $24.00
90744 <1% 322 $23.38
84155 <1% 14 $18.35
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12 $7.02
94761 <1% 18 $6.58
97010 <1% 223 $4.50
91306 <1% 115 $0.20
91301 <1% 897 $0.12
90648 0% 64 $0.00
90700 0% 87 $0.00
90685 0% 437 $0.00
3077F 0% 217 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 32 $0.00
91300 0% 33 $0.00
3051F 0% 12 $0.00
3079F 0% 850 $0.00
90698 0% 734 $0.00
91303 0% 46 $0.00
90680 0% 551 $0.00
90656 0% 51 $0.00
90696 0% 99 $0.00
3044F 0% 394 $0.00
3080F 0% 92 $0.00
90619 0% 130 $0.00
91307 0% 71 $0.00
3075F 0% 299 $0.00
2023F 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSPENCER, GREGORY (CHIEF MEDICAL OFFICER)
Same official

Other billing entities under SPENCER, GREGORY

Full network →
ProviderLocationPaid
Crystal Run Healthcare Physicians LLPGoshen, NY$202K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.